Home/Filings/4/0001479290-25-000004
4//SEC Filing

Foley Mark J 4

Accession 0001479290-25-000004

CIK 0001479290other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:33 PM ET

Size

5.8 KB

Accession

0001479290-25-000004

Insider Transaction Report

Form 4
Period: 2024-12-31
Foley Mark J
DirectorCEO
Transactions
  • Award

    Common Stock

    2024-12-31$2.18/sh+1,000$2,185996,935 total
Holdings
  • Common Stock

    (indirect: See footnote)
    110,913
Footnotes (2)
  • [F1]These shares were acquired by Mr. Foley under the Issuer's 2014 Employee Stock Purchase Plan on December 31,2024 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002.

Issuer

Revance Therapeutics, Inc.

CIK 0001479290

Entity typeother

Related Parties

1
  • filerCIK 0001529196

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:33 PM ET
Size
5.8 KB